Mainz Biomed, Microba Life Sciences Partner to Develop Pancreatic Cancer Screening Test
The partners will collaborate to develop novel microbiome biomarkers for a screening test in development called PancAlert.
NYU Langone Perlmutter Cancer Center to Validate Biological Dynamics Pancreatic Cancer Test
The collaboration will test retrospective samples from more than 200 patients to validate Biological Dynamics' platform.
Immunovia Reducing Headcount, Realigning to Focus on Pancreatic Cancer Test Commercialization
The firm said it will reduce in-house R&D staff from its operations in Lund, Sweden, as it focuses on bringing the ImmRay PanCan-d test to the US market.
The firm has commercialized its pancreatic cancer test and has its sights set on an ovarian cancer test launching in 2023.
Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients
The firm will evaluate its epigenomic liquid biopsy test to detect pancreatic cancer among patients considered high-risk for the disease due to their diabetes.
Oct 11, 2022
Apr 22, 2021